Syncom Formulations (India) Limited

Healthcare · Pharmaceuticals & Biotechnology

NSE: SYNCOMF BSE: 524470

₹25.08

Sept. 30, 2026 · NSE · nse_bhavcopy

Peers in Pharmaceuticals & Biotechnology

The largest companies in the same industry by market cap. This company ranks #76 of 184. PE, ROE, 1Y return and scores come from the daily/weekly precomputed snapshot.

Company	Market cap (₹ Cr)	PE (TTM)	ROE	1Y return	Div. yield	Quality	Valuation	Momentum
Sun Pharmaceutical Industries Limited	435,863	146.5	13.7%	11.0%	—	72	8	30
Divi's Laboratories Limited	246,660	83.9	15.3%	62.7%	0.32%	70	4	51
Torrent Pharmaceuticals Limited	162,454	78.2	12.2%	34.6%	0.79%	56	0	31
Zydus Lifesciences Limited	115,910	33.3	17.3%	17.2%	0.09%	74	24	84
Cipla Limited	108,736	35.4	11.2%	-11.0%	0.97%	73	29	62
Laurus Labs Limited	106,969	122.5	17.1%	127.1%	—	78	24	53
Mankind Pharma Limited	103,406	47.4	11.7%	2.6%	—	68	12	86
Dr. Reddy's Laboratories Limited	102,916	154.7	10.9%	-0.9%	—	62	33	71
Syncom Formulations (India) Limited (this stock)	2,358	27.0	18.4%	52.8%	0.40%	82	19	91

Valuation multiples

Current only. Market cap is the whole company's; sales/EBITDA are trailing-twelve-month standalone; debt and cash come from the latest filed standalone balance sheet (March 31, 2026). EBITDA = PBT + interest + depreciation.

Enterprise value

₹2,353 Cr

EV / EBITDA

19.6x

EV / Sales

4.76x

Market cap / Sales

4.77x

Earnings yield

3.71%

Quarterly Financials

Download CSV

Standalone Consolidated

↑ Positive

Quarterly Revenue

Jun 2026 quarterly revenue is Rs 132 Cr, up 8.1% YoY.

↑ Positive

Quarterly Net Profit

Jun 2026 quarterly net profit is Rs 25 Cr, up 56.3% YoY.

Period end	Revenue (₹ Cr)	PBT (₹ Cr)	Net profit (₹ Cr)	Basic EPS
June 30, 2026	125	32	25	₹0.2600
March 31, 2026	134	33	25	₹0.2600
Dec. 31, 2025	115	25	19	₹0.2300
Sept. 30, 2025	121	22	17	₹0.1800
June 30, 2025	117	20	16	₹0.2100
March 31, 2025	148	23	18	₹
Dec. 31, 2024	127	17	13	₹0.1400
Sept. 30, 2024	101	15	11	₹0.1600
June 30, 2024	87	10	8	₹0.1100
March 31, 2024	73	9	7	₹0.0900
Dec. 31, 2023	63	9	6	₹0.0900
Sept. 30, 2023	62	8	6	₹0.0800
June 30, 2023	59	6	4	₹0.0700

Quarterly income statement (standalone, ₹ Cr)

Indicator	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23
Total income (before exceptional items)	132	148	120	127	123	131	106	88	76	68	66	61	68
Operating revenue	125	134	115	121	117	127	101	87	73	63	62	59	61
Other income	8	14	5	5	6	4	4	1	3	4	4	2	7
Operating expenses	99	113	93	103	101	112	90	76	64	57	56	53	55
Operating profit	26	21	21	19	16	15	12	10	9	7	6	6	6
Operating profit margin	20.7%	16.0%	18.5%	15.4%	13.5%	11.5%	11.8%	12.1%	12.0%	10.7%	9.8%	10.4%	9.7%
Depreciation	2	2	1	1	1	1	1	1	1	1	1	1	1
Interest	0	0	0	0	0	0	0	0	1	1	1	1	1
Exceptional items, gain / (loss)	—	-0	—	—	0	—	-0	—	—	-0	—	—	0
Profit before tax	32	33	25	22	20	17	15	10	9	9	8	6	10
Tax	7	8	6	6	5	4	4	2	2	2	2	2	2
Net profit	25	25	19	—	16	13	11	8	7	6	6	4	8
EPS	0.26	0.26	0.23	0.18	0.21	0.14	0.16	0.11	0.09	0.09	0.08	0.07	0.10
Net profit (TTM)	—	—	—	—	47	38	32	27	24	25	23	20	20
EPS (TTM)	0.93	0.88	0.76	0.69	0.62	0.50	0.45	0.37	0.33	0.34	0.31	0.29	0.25

Total income excludes exceptional items, which are shown on their own row. Trendlyne and Screener fold exceptional items into revenue or other income, so their totals differ from this table by exactly that row.

Annual Financials

Year ended	Revenue (₹ Cr)	PBT (₹ Cr)	Net profit (₹ Cr)
March 31, 2026	487	101	76
March 31, 2025	463	65	49
March 31, 2024	258	32	24

Annual income statement (standalone, ₹ Cr; CAGR to the latest year)

Indicator	CAGR 3Y	CAGR 5Y	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18	Mar 17
Total income (before exceptional items)	29.3%	15.5%	518^†	—	271^†	239^†	232^†	252^†	211^†	192^†	163^†	188^†
Operating revenue	29.4%	14.7%	487	463	258	225^†	220^†	245^†	206^†	187^†	159^†	184^†
Other income	—	—	31^†	—	13^†	15^†	12^†	7^†	5^†	5^†	4^†	3^†
Operating expenses	—	—	409^†	—	231^†	205^†	200^†	207^†	189^†	175^†	—	168^†
Operating profit	57.8%	15.3%	77^†	—	28^†	20^†	19^†	38^†	17^†	12^†	—	16^†
Operating profit margin	—	—	15.9%^†	—	10.8%^†	8.7%^†	8.9%^†	15.5%^†	8.1%^†	6.3%^†	—	8.8%^†
Depreciation	—	—	7^†	—	5^†	5^†	4^†	4^†	4^†	4^†	4^†	3^†
Interest	—	—	1^†	—	4^†	3^†	1^†	0^†	0^†	0^†	—	0^†
Exceptional items, gain / (loss)	—	—	0^†	—	-0^†	0^†	0^†	0^†	0^†	0^†	-0^†	0^†
Profit before tax	55.8%	19.8%	101	65	32	27^†	26^†	41^†	17^†	13^†	12^†	16^†
Tax	—	—	25^†	—	8^†	6^†	6^†	12^†	3^†	2^†	3^†	5^†
Net profit	55.9%	21.1%	76	49	24	20^†	20^†	29^†	—	11^†	9^†	11^†
EPS	52.1%	18.3%	0.88^†	—	0.33^†	0.25^†	0.26^†	0.38^†	0.16^†	—	—	—

^† Derived: the sum of that fiscal year's four quarterly filings (a real annual filing is used wherever one exists). Checked against filed annual figures, the sum lands within 0.5% for about 94% of company-years.

Annual ratios (standalone)

Ratio	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18	Mar 17
Operating margin	15.9%^†	—	10.8%^†	8.7%^†	8.9%^†	15.5%^†	8.1%^†	6.3%^†	—	8.8%^†
EBIT margin	20.9%^†	—	14.0%^†	13.2%^†	12.5%^†	16.7%^†	8.7%^†	6.9%^†	—	8.8%^†
PBT margin	20.7%	14.0%	12.3%	11.8%^†	11.9%^†	16.6%^†	8.4%^†	6.8%^†	7.6%^†	8.6%^†
Net margin	15.6%	10.6%	9.1%	8.9%^†	9.0%^†	11.9%^†	—	5.9%^†	5.5%^†	5.7%^†
Interest coverage	91.99x^†	—	8.14x^†	9.49x^†	20.32x^†	151.14x^†	38.70x^†	58.93x^†	—	57.25x^†
Dividend payout	0.0%^†	—	0.0%^†	0.0%^†	0.0%^†	0.0%^†	0.0%^†	—	—	—
Earnings retention	100.0%^†	—	100.0%^†	100.0%^†	100.0%^†	100.0%^†	100.0%^†	—	—	—
Current ratio	3.20x	4.61x	—	—	—	—	—	—	—	—
Quick ratio	2.58x	3.90x	—	—	—	—	—	—	—	—
Debt to equity	0.00x	0.01x	—	—	—	—	—	—	—	—
Return on equity	18.4%	14.4%	—	—	—	—	—	—	—	—
Return on assets	14.4%	11.9%	—	—	—	—	—	—	—	—
Return on capital employed	23.8%^†	—	—	—	—	—	—	—	—	—
Asset turnover	0.92x	1.13x	—	—	—	—	—	—	—	—

Margins and asset turnover use operating revenue (interest earned for banks, excluding other income), not total income. Liquidity, leverage and return ratios need a filed standalone balance sheet, which exists only for recent years; returns use year-end equity/assets. Dividend payout is shown only for companies with a dividend record. † = built from a summed fiscal year.

Revenue Mix

Data unavailable.

Cash Flow

Year ended	Operating (₹ Cr)	Investing (₹ Cr)	Financing (₹ Cr)	Capex (₹ Cr)	Free Cash Flow (₹ Cr)
March 31, 2026	58	-51	-3	12	47
March 31, 2025	23	-18	-68	10	13
March 31, 2024	-6	84	-15	8	-14

Balance Sheet (standalone)

Year ended	Total Assets (₹ Cr)	Total Equity (₹ Cr)	Reserves (₹ Cr)	Borrowings, Current (₹ Cr)	Borrowings, Non-current (₹ Cr)	Current Assets (₹ Cr)	Current Liabilities (₹ Cr)	Cash & Equivalents (₹ Cr)	Net Block (₹ Cr)	Inventory (₹ Cr)
March 31, 2026	529	412	318	1	0	326	102	5	90	63
March 31, 2025	410	340	246	4	0	267	58	1	78	41
March 31, 2024	—	—	—	—	—	—	—	—	—	—

Financial charts

Trend charts drawn from the standalone income-statement and ratio tables above (oldest year on the left); a gap means that period has no figure. Annual years marked † in the tables are derived from four quarters.